Share on StockTwits
 

Sabra Healthcare REIT Inc. (NASDAQ:SBRA) issued an update on its FY14 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $2.19-2.23 for the period, compared to the Thomson Reuters consensus estimate of $2.18, StockRatingsNetwork.com reports.

Shares of Sabra Healthcare REIT Inc. (NASDAQ:SBRA) traded up 0.32% on Thursday, hitting $28.06. 192,239 shares of the company’s stock traded hands. Sabra Healthcare REIT Inc. has a 52 week low of $21.55 and a 52 week high of $32.40. The stock’s 50-day moving average is $26.35 and its 200-day moving average is $25.34. The company has a market cap of $1.063 billion and a price-to-earnings ratio of 54.84.

Several analysts have recently commented on the stock. Analysts at BMO Capital Markets downgraded shares of Sabra Healthcare REIT to an underperform rating in a research note to investors on Thursday, January 2nd. On a related note, analysts at Zacks downgraded shares of Sabra Healthcare REIT from an outperform rating to a neutral rating in a research note to investors on Tuesday, December 31st. They now have a $30.00 price target on the stock. Finally, analysts at Raymond James raised their price target on shares of Sabra Healthcare REIT from $27.00 to $30.00 in a research note to investors on Friday, November 1st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of Hold and a consensus target price of $30.60.

Sabra Health Care REIT, Inc (NASDAQ:SBRA) as a wholly owned subsidiary of Sun Healthcare Group, Inc, a provider of nursing, rehabilitative and related specialty healthcare services to the senior population in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.